Not Yet RecruitingNot Applicable

Pulmonary Hypertension Screening in Scleroderma

35 participantsStarted 2025-09

Plain-language summary

Screening for pulmonary hypertension in scleroderma patients

Who can participate

Age range18 Years – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * . Inclusion criteria: aga ≥18 years confirmed diagnosis of scleroderma Exclusion Criteria: * aga \<18 years * patients refused to participate

What they're measuring

Screening for pulmonary hypertension in scleroderma patients

Timeframe: baseline

Trial details

NCT IDNCT07186439

SponsorAssiut University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2026-09

Contact for this trial

Esraa Sayed Abdalzeaz, Resident doctor

01093243340 esraasayedabdalzeaz@gmail.com

View on ClinicalTrials.gov More PHTN in Scleroderma Patients trials